MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

NCT06735508 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: mRNA Neoantigen Vaccine
DRUG: Adebrelimab

Sponsor

Guangdong Provincial People's Hospital

Collaborators

[object Object]